Acutus Medical Inc.

16.30-0.3100-1.87%Vol 78.34K1Y Perf -38.25%
Jun 14th, 2021 16:00 DELAYED
BID16.30 ASK16.37
Open16.55 Previous Close16.61
Pre-Market- After-Market-
 - -  - -%
Target Price
22.60 
Analyst Rating
— — 0.00
Potential %
38.65 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     57.46
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap458.42M 
Earnings Rating
Price Range Ratio 52W %
18.41 
Earnings Date
12th May 2021

Today's Price Range

16.1616.86

52W Range

11.1838.99

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-6.27%
1 Month
19.41%
3 Months
-9.44%
6 Months
-45.83%
1 Year
-38.25%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AFIB16.30-0.3100-1.87
AAPL130.483.13002.46
GOOG2 527.0413.11000.52
MSFT259.892.00000.78
XOM62.07-0.1000-0.16
WFC45.15-0.5300-1.16
JNJ165.370.41000.25
FB336.775.51001.66
GE13.47-0.2200-1.61
JPM157.57-2.7200-1.70
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.80-1.08-35.00
Q04 2020-0.81-0.99-22.22
Q03 2020-1.38-1.1814.49
Q02 2020--32.24-
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.70
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume78.34K
Shares Outstanding28.12M
Trades Count1.26K
Dollar Volume6.20M
Avg. Volume322.80K
Avg. Weekly Volume139.59K
Avg. Monthly Volume258.16K
Avg. Quarterly Volume312.40K

Acutus Medical Inc. (NASDAQ: AFIB) stock closed at 16.3 per share at the end of the most recent trading day (a -1.87% change compared to the prior day closing price) with a volume of 78.35K shares and market capitalization of 458.42M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 291 people. Acutus Medical Inc. CEO is Vincent J. Burgess.

The one-year performance of Acutus Medical Inc. stock is -38.25%, while year-to-date (YTD) performance is -43.42%. AFIB stock has a five-year performance of %. Its 52-week range is between 11.18 and 38.99, which gives AFIB stock a 52-week price range ratio of 18.41%

Acutus Medical Inc. currently has a PE ratio of -32.50, a price-to-book (PB) ratio of 4.66, a price-to-sale (PS) ratio of 43.78, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -90.80%, a ROC of -45.37% and a ROE of 159.29%. The company’s profit margin is -%, its EBITDA margin is -980.90%, and its revenue ttm is $10.47 Million , which makes it $0.37 revenue per share.

Of the last four earnings reports from Acutus Medical Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.70 for the next earnings report. Acutus Medical Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Acutus Medical Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Acutus Medical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Acutus Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Acutus Medical Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 55.12, ATR14 : 1.08, CCI20 : 57.00, Chaikin Money Flow : 0.03, MACD : 0.83, Money Flow Index : 53.53, ROC : 14.07, RSI : 58.12, STOCH (14,3) : 57.50, STOCH RSI : 0.00, UO : 45.84, Williams %R : -42.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Acutus Medical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Acutus Medical Inc.

Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.

CEO: Vincent J. Burgess

Telephone: +1 442 232-6080

Address: 2210 Faraday Avenue, Carlsbad 92008, CA, US

Number of employees: 291

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

News

Stocktwits